[Molecular prognostic factors and pathogenesis of endometrial cancer].
OBJECTIVE
To evaluate the importance of molecular markers for prognosis and pathogenesis of endometrial carcinoma.


METHODS
A review article.


METHODS
Department of Medical Genetics and Fetal Medicine, University Hospital, Olomouc, Department of Obstetrics and Gynecology, University Hospital, Olomouc.


METHODS
This article reviews the current knowledge of the molecular changes in the development of endometrial cancer, and their possible importance for the patient's prognosis.


CONCLUSIONS
The new molecular biomarkers are apparently going to play a significant role in the management of endometrial carcinoma treatment in the near future.
Mícková
I
I
Department of Medical Genetics and Fetal Medicine, University Hospital, Olomouc.
Pilka
R
R
L'ubuský
M
M
Kudela
M
M
D014408:Biomarkers, Tumor / Q000032:analysis; D016889:Endometrial Neoplasms / Q000175:diagnosis* / Q000235:genetics; D005260:Female; D006801:Humans; D011379:Prognosis
D014408:Biomarkers, Tumor